Miguel Alcántara-Mimbela

Miguel Alcántara-Mimbela

Auto-generated profile, based on publicly available information

Miguel Alcántara-Mimbela

Universidad Nacional Pedro Ruiz Gallo, Facultad de Ciencias Biológicas, Lambayeque, Perú

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2021 in Revista de la Facultad de Medicina Humana
Verified
Journal Article
Open access
PDF file
JCJohnny Leandro Saavedra Camacho
Johnny Leandro Saavedra Camacho
SISebastian Iglesias
Sebastian Iglesias
MAMiguel Alcántara-Mimbela
Miguel Alcántara-Mimbela
LCLizbeth Maribel Córdova
Lizbeth Maribel Córdova
Introduction: Genomic analysis of samples from documented COVID-19 cases can be used successfully to help track sources of Sars-Cov-2 infection, which can be quarantined to prevent the recurrent spread of the disease around the world. Objective: To describe the SARS-CoV-2 sequences isolated from Peruvian patients. Methods: All genomes published up to March 2021, uploaded in the GISAID and Nextstrain repository, were selected. All data is on the web in a public way; In addition, the information was filtered by continent, country, region, clade, lineage, and sex from March 2020 to February 2021. Results: It was evidenced that the region with the most isolated genomes was Lima, the most frequent clade is GR, the viral lineage B.1.1 is the most frequent and persistent in time and most of the genomes were isolated from people of the female sex.Conclusions: The clade GR is common to all South American countries and the European and Asian continents, followed by clades G and GH with greater frequency; on the other hand, the most persistent viral lineage in Peru is B.1.1, this being not common with other countries. Introducción: El análisis genómico de muestras de casos documentados de COVID-19 puede usarse con éxito para ayudar a rastrear fuentes de infección por Sars-Cov-2, que pueden ponerse en cuarentena para prevenir la propagación recurrente de la enfermedad en todo el mundo. Objetivo: Describir las secuencias de SARS-CoV-2 aisladas de pacientes peruanos. Métodos: Se seleccionaron todos los genomas publicados hasta marzo del 2021, subidos en el repositorio de GISAID y Nextstrain. Todos los datos están en la web de manera pública; además se filtró la información por continente, país, región, clado, linaje y sexo desde marzo de 2020 hasta febrero de 2021. Resultados: Se evidenció que la región con la mayoría de los genomas aislados fue Lima, el clado más frecuente es el GR, el linaje viral B.1.1 es el más frecuente y persistente en tiempo y la mayor parte de genomas fueron aislados de personas del sexo femenino. Conclusiones: El clado GR es común para todos los países sudamericanos y los continentes europeos y asiáticos, seguido de los clados G y GH con mayor frecuencia; por otro lado, el linaje viral más persistente en Perú es el B.1.1, siendo este dato no común con otros países.

30 March 2023 in Revista Experiencia en Medicina del Hospital Regional Lambayeque
Verified
Journal Article
Open access
PDF file
JSJohnny Leandro Saavedra-Camacho
Johnny Leandro Saavedra-Camacho
SISebastian Iglesias
Sebastian Iglesias
MAMiguel Alcántara-Mimbela
Miguel Alcántara-Mimbela
LCLizbeth Maribel Córdova
Lizbeth Maribel Córdova
JAJohana Acosta-Quiroz
Johana Acosta-Quiroz
Resumen Objective: To estimate the prevalence of traffic accidents between 2012 and 2018 in Peru. Material and methods: A retrospective descriptive study was conducted using data on traffic accidents in Peru from the National Institute of Statistics and Informatics (INEI) from 2012 to 2018. The data on traffic accidents in Peru from the National Institute of Statistics and Informatics (INEI) from 2012 to 2018 were reviewed, taking into account the number of injured and deceased for that reason, in order to then calculate the lethality. Similarly, data were obtained on the types of traffic accidents that occurred in the departments of the country in question during 2018. Results: Between the years 2012-2018, 560,745 traffic accidents were reported. During 2012, 94 923 traffic accidents were reported, resulting in 54 572 injured persons, 3 313 fatalities with a fatality rate of 3.49 %. 102 762 traffic accidents were reported during 2013 with 59 453 injured, 3 110 fatalities with a fatality of 3.03 %. In 2014 101 104 traffic accidents were reported with 58 148 injured, 2 798 fatalities and a lethality of 2.77 %. In 2015 95 532 traffic accidents were reported, 56 499 injured, 2 965 fatalities and a lethality of 3.10 %. During 2016, 89 304 traffic accidents were reported, 53 776 injured, 2 696 fatalities and a fatality rate of 3.02 %. In 2017, 88168 traffic accidents were reported, 53 776 injured, 2 826 fatalities and a fatality rate of 3.21 %. 90 056 traffic accidents were reported in 2018, 61 512 injured, 3 244 fatalities and a fatality of 3.60 %.

1 February 2021 in medRxiv
Verified
Preprint
Open access
PDF file
SISebastian Iglesias
Sebastian Iglesias
ARArturo Rafael-Heredia
Arturo Rafael-Heredia
EREric Ricardo Rojas-Tello
Eric Ricardo Rojas-Tello
WOWashington A. Ortiz-Uribe
Washington A. Ortiz-Uribe
LRLeveau-Bartra Walter Román
Leveau-Bartra Walter Román
VFVirgilio E. Failoc-Rojas
Virgilio E. Failoc-Rojas
Objective This study examined the laboratory results of COVID-19 patients from a hospital in the Peruvian Amazon and their clinical prognosis. Methods An analytical cross-sectional study was carried out whose purpose was to identify the laboratory tests of patients with COVID-19 and mortality in a hospital in Ucayali, Peru during the period from March 13 to May 9, 2020, selecting a total of 127 with Covid-19. Mean and the standard deviation was described for age, leukocytes, neutrophils, platelets, RDW-SD; median and interquartile range for the variables lymphocyte, RN / L, fibrinogen, CRP, D-dimer, DHL, hematocrit, monocytes, eosinophils. Results No differences were observed in this population regarding death and sex (OR: 1.31; 95% CI 0.92 to 1.87), however, it was observed that, for each one-year increase, the probability of death increased by 4% (PR: 1.04, 95% CI 1.03 to 1.05). The IRR (Incidence Risk Ratio) analysis for the numerical variables showed results strongly associated with hematological values such as Leukocytes (scaled by 2500 units) (IRR: 1.08, 95% CI 1.03 to 1.13), neutrophils (scaled by 2500 units) (IRR: 1.08; 95% CI 1.03 to 1.13), on the contrary, it is observed that the increase of 1000 units in lymphocytes, the probability of dying decreased by 48% (IRR: 0.52; 95% CI 0.38 to 071). Conclusion Parameters such as leukocytes and neutrophils were statistically much higher in patients who died.